Literature DB >> 30136611

HIV transgene expression impairs K+ channel function in the pulmonary vasculature.

Gema Mondejar-Parreño1,2, Daniel Morales-Cano1,2, Bianca Barreira1,2, María Callejo1,2, Jesús Ruiz-Cabello2,3,4,5, Laura Moreno1,2, Sergio Esquivel-Ruiz1,2, Alistair Mathie6, Ghazwan Butrous6, Francisco Perez-Vizcaino1,2, Angel Cogolludo1,2.   

Abstract

Human immunodeficiency virus (HIV) infection is an established risk factor for pulmonary arterial hypertension (PAH); however, the pathogenesis of HIV-related PAH remains unclear. Since K+ channel dysfunction is a common marker in most forms of PAH, our aim was to analyze whether the expression of HIV proteins is associated with impairment of K+ channel function in the pulmonary vascular bed. HIV transgenic mice (Tg26) expressing seven of the nine HIV viral proteins and wild-type (WT) mice were used. Hemodynamic assessment was performed by echocardiography and catheterization. Vascular reactivity was studied in endothelium-intact pulmonary arteries. K+ currents were recorded in freshly isolated pulmonary artery smooth muscle cells (PASMC) using the patch-clamp technique. Gene expression was assessed using quantitative RT-PCR. PASMC from Tg26 mice had reduced K+ currents and were more depolarized than those from WT. Whereas voltage-gated K+ channel 1.5 (Kv1.5) currents were preserved, pH-sensitive noninactivating background currents ( IKN) were nearly abolished in PASMC from Tg26 mice. Tg26 mice had reduced lung expression of Kv7.1 and Kv7.4 channels and decreased responses to the Kv7.1 channel activator L-364,373 assessed by vascular reactivity and patch-clamp experimental approaches. Although we found pulmonary vascular remodeling and endothelial dysfunction in Tg26 mice, this was not accompanied by changes in hemodynamic parameters. In conclusion, the expression of HIV proteins in vivo impairs pH-sensitive IKN and Kv7 currents. This negative impact of HIV proteins in K+ channels was not sufficient to induce PAH, at least in mice, but may play a permissive or accessory role in the pathophysiology of HIV-associated PAH.

Entities:  

Keywords:  HIV; Kv7; TASK channels; potassium channels; pulmonary hypertension

Mesh:

Substances:

Year:  2018        PMID: 30136611     DOI: 10.1152/ajplung.00045.2018

Source DB:  PubMed          Journal:  Am J Physiol Lung Cell Mol Physiol        ISSN: 1040-0605            Impact factor:   5.464


  6 in total

1.  World AIDS Day 2021: highlighting the pulmonary complications of HIV/AIDS.

Authors:  Rory E Morty; Alison Morris
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2021-11-24       Impact factor: 6.011

2.  HIV and Schistosoma Co-Exposure Leads to Exacerbated Pulmonary Endothelial Remodeling and Dysfunction Associated with Altered Cytokine Landscape.

Authors:  Sandra Medrano-Garcia; Daniel Morales-Cano; Bianca Barreira; Alba Vera-Zambrano; Rahul Kumar; Djuro Kosanovic; Ralph Theo Schermuly; Brian B Graham; Francisco Perez-Vizcaino; Alistair Mathie; Rajkumar Savai; Soni Pullamseti; Ghazwan Butrous; Edgar Fernández-Malavé; Angel Cogolludo
Journal:  Cells       Date:  2022-08-04       Impact factor: 7.666

3.  Mice with humanized immune system as novel models to study HIV-associated pulmonary hypertension.

Authors:  Valerie J Rodriguez-Irizarry; Alina C Schneider; Daniel Ahle; Justin M Smith; Edu B Suarez-Martinez; Ethan A Salazar; Brianyell McDaniel Mims; Fahmida Rasha; Hanna Moussa; Naima Moustaïd-Moussa; Kevin Pruitt; Marcelo Fonseca; Mauricio Henriquez; Matthias A Clauss; Matthew B Grisham; Sharilyn Almodovar
Journal:  Front Immunol       Date:  2022-08-05       Impact factor: 8.786

4.  HIV X4 Variants Increase Arachidonate 5-Lipoxygenase in the Pulmonary Microenvironment and are associated with Pulmonary Arterial Hypertension.

Authors:  Brandy E Wade; Kristi M Porter; Sharilyn Almodovar; Justin M Smith; Robert A Lopez-Astacio; Kaiser Bijli; Bum-Yong Kang; Sushma K Cribbs; David M Guidot; Deborah Molehin; Bryan K McNair; Laura Pumarejo-Gomez; Jaritza Perez Hernandez; Ethan A Salazar; Edgar G Martinez; Laurence Huang; Cari F Kessing; Edu B Suarez-Martinez; Kevin Pruitt; Priscilla Y Hsue; William R Tyor; Sonia C Flores; Roy L Sutliff
Journal:  Sci Rep       Date:  2020-07-16       Impact factor: 4.379

5.  Transcriptomic profile of cationic channels in human pulmonary arterial hypertension.

Authors:  Francisco Perez-Vizcaino; Angel Cogolludo; Gema Mondejar-Parreño
Journal:  Sci Rep       Date:  2021-08-04       Impact factor: 4.379

Review 6.  Ion channels as convergence points in the pathology of pulmonary arterial hypertension.

Authors:  Thibault R H Jouen-Tachoire; Stephen J Tucker; Paolo Tammaro
Journal:  Biochem Soc Trans       Date:  2021-08-27       Impact factor: 5.407

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.